The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Pathology and physiopathology of adenomyosis
Abstract
Adenomyosis is defined by the presence of endometrial mucosa within the myometrium. This probably occurs by invagination of the basalis endometrium into the myometrium. The process of invagination and intramyometrial spreading may be facilitated by the non-cyclic, anti-apoptotic activity of the basalis associated with relative hyper-oestrogenic states. Most cases of adenomyosis are discovered in multiparous women during the 'transitional' years (40-50 years), and the condition is associated with menorrhagia, dysmenorrhoea, endometrial polyps and leiomyomata uteri. Endometrioid adenocarcinoma is often associated with adenomyosis, is frequently of early stage and low histological grade, is hormone-sensitive, and has an excellent prognosis. Extension of malignant growth into foci of adenomyosis has no adverse effect on prognosis. Definite diagnosis and treatment of adenomyosis are obtained by hysterectomy. Although adenomyotic endometrial glands are hormone-sensitive, exogenous progestogenic agents are ineffective for the treatment of adenomyosis. Anti-oestrogenic danazol and gonadotrophin-releasing hormone (GnRH) analogues induce suppression of adenomyosis, but their use must be of short duration. Surgical extirpation, therefore, is the best therapeutic option.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adenomyosis, defined as the presence of endometrial glands and stroma infiltrated deep and haphazardly into the myometrium [1], is a common gynecologic disorder with poorly understood pathogenesis and pathophysiology [2,3,4].”
From The Pathogenesis of Adenomyosis vis-à-vis Endometriosis (2020) · cites this paper as [2]
Citations
Cites
Amant, F. C., Moerman, P., Neven, P., Timmerman, D., Limbergen, E. V., & Vergote, I. B. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67063-8 · Cited by 1,639
The elusive adenomyosis of the uterus—revisited
Bird, C. C., McElin, T. W., & Manalo-Estrella, P. (1972) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(72)90781-8 · Cited by 531
Pathophysiology of adenomyosis
Ferenczy, A. S. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.4.312 · Cited by 512
Bazot, M., Cortez, A., Daraï, É., Rouger, J., Chopier, J., Antoine, J.-M., & Uzan, S. (2001) · Human Reproduction · doi:10.1093/humrep/16.11.2427 · Cited by 501
Azziz, R. (1989) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(21)00148-0 · Cited by 316
Cytokeratins of normal epithelia and some neoplasms of the female genital tract.
Moll, R., Levy, R., Czernobilsky, B., Hohlweg-Majert, P., Dallenbach-Hellweg, G., & Franke, W. W. (1983) · PubMed · Cited by 229
Adenomyosis: symptoms, histology, and pregnancy terminations
Levgur, M. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00659-6 · Cited by 209
Uterine adenomyosis in the infertility clinic
Devlieger, R. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg010 · Cited by 206
Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle
OTSUKI, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91051-0 · Cited by 187
Confirmation of the preoperative diagnoses for hysterectomy
Lee, N. C., Dicker, R. C., RUBIN, G. L., & Ory, H. W. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(84)90366-1 · Cited by 172
Flagged first, then by citations
Research works printed but not linked: 1
- Lewinski, 1931, Beitrag zur Frage der adenomiosis, Zentralblatt fur Gynakologie, 55, 2163
Cited by
Sorted by citations
Items 101–200 of 358
Laparoscopic Radiofrequency Thermal Ablation for Uterine Adenomyosis
Scarperi, S., Pontrelli, G., Campana, C., Steinkasserer, M., Ercoli, A., Minelli, L., Bergamini, V., & Ceccaroni, M. (2015) · JSLS Journal of the Society of Laparoscopic & Robotic Surgeons · doi:10.4293/jsls.2015.00071 · Cited by 32
Zhu, B., Chen, Y., Zhang, H., Liu, X., & Guo, S. (2015) · Reproductive Sciences · doi:10.1177/1933719115572479 · Cited by 31
Current facts constituting an understanding of the nature of adenomyosis
Aleksandrovych, V., Basta, P., & Gil, K. (2018) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/79176 · Cited by 31
Elsherbiny, N. M., Ahmed, E., Kader, G. A., Abdel–Mottaleb, Y., El-Sayed, M. H., Youssef, A. M., & Zaitone, S. A. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.050 · Cited by 32
“and IL1β; this agrees with a previous report [59].”
ResultMusa, F., Frey, M. K., Im, H. B., Chekmareva, M. A., Ellenson, L. H., & Holcomb, K. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.06.051 · Cited by 31
Zhou, L., Yin, M., Ma, M., Wang, Y., & Kuang, Y. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2019.03.101 · Cited by 30
Bourdon, M., Santulli, P., Doridot, L., Jeljeli, M. M., Chêne, C., Chouzenoux, S., Nicco, C., Marcellin, L., Chapron, C., & Batteux, F. (2021) · Molecular Human Reproduction · doi:10.1093/molehr/gaab053 · Cited by 30
Fertility preservation in women with benign gynaecological conditions
Santulli, P., Blockeel, C., Bourdon, M., Coticchio, G., Campbell, A., Vos, M. D., Macklon, K. T., Pinborg, A. B., & García-Velasco, J. A. (2023) · Human Reproduction Open · doi:10.1093/hropen/hoad012 · Cited by 30
“Adenomyosis, defined as the presence of ectopic endometrial islets within the myometrium (Bergeron et al., 2006), is frequently associated with endometriosis and can cause pelvic pain, abnormal uterine bleeding, and impaired fertility (Vercellini et al.”
Adenomyosis: A Challenge in Clinical Gynecology
Cockerham, A. Z. (2012) · Journal of Midwifery & Women s Health · doi:10.1111/j.1542-2011.2011.00117.x · Cited by 31
Adenomyosis and female fertility: A critical review of the evidence
Sunkara, S. K., & Khan, K. S. (2012) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2011.624208 · Cited by 30
“From the remaining 19 articles, we obtained full manuscripts, and following scrutiny of these, 12 were excluded as they were reviews (Devlieger et al. 2003; Ferenczy 1998; Ota et al. 1998; Reinhold et al. 1998; Tulandi 1998; Angelini et al. 2005; Matalliotakis et al. 2005; Bergeron et al. 2006; Leyendecker et al. 2006…”
BackgroundPerelló, M. F., Martínez‐Zamora, M. Á., Torres, X., Munrós, J., Balasch, J., & Carmona, F. (2016) · Gynecologic and Obstetric Investigation · doi:10.1159/000447633 · Cited by 30
Different macrophages equally induce EMT in endometria of adenomyosis and normal
An, M., Dong, L., Yuan, M., Li, Q., Zhang, L., & Wang, G. (2017) · Reproduction · doi:10.1530/rep-17-0174 · Cited by 29
Immune-inflammatory predictors of the pelvic pain syndrome associated with adenomyosis
Orazov, M. R., Radzinsky, V. E., Носенко, О. М., Khamoshina, M. B., Духин, А. О., & Lebedeva, М. G. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1399696 · Cited by 29
“rhea, chronic pelvic pain and subfertility [1,2].”
Ulipristal acetate use in adenomyosis: A randomized controlled trial
Capmas, P., Brun, J.-L., Legendre, G., Koskas, M., Merviel, P., & Fernandez, H. (2020) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2020.101978 · Cited by 31
Global prevalence of adenomyosis and endometriosis: a systematic review and meta-analysis
Wang, M.-H., Chen, J., Qi, X., Li, Z., & Huang, Y. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01483-z · Cited by 36
Chen, Y., Zhu, B., Zhang, H., Ding, D., Liu, X., & Guo, S. (2014) · Reproductive Sciences · doi:10.1177/1933719113518984 · Cited by 28
“Adenomyosis is a rather common gynecologic disorder with a poorly understood pathogenesis.(1) In premenopausal women who underwent hysterectomy because of adenomyosis, dysmenorrhea is the most common complaint.”
BackgroundDienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis
Takeuchi, A., Koga, K., Miyashita‐Ishiwata, M., Makabe, T., Sue, F., Harada, M., Hirata, T., Hirota, Y., Fujii, T., & Osuga, Y. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.10.053 · Cited by 28
Dior, U. P., Nisbet, D., Fung, J. N., Foster, G., Healey, M., Montgomery, G. W., Rogers, P. A. W., Holdsworth‐Carson, S. J., & Girling, J. E. (2018) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2018.09.780 · Cited by 28
MRI of Adenomyosis: Where Are We Today?
Zhang, M., Bazot, M., Tsatoumas, M., Munro, M. G., & Reinhold, C. (2022) · Canadian Association of Radiologists Journal · doi:10.1177/08465371221114197 · Cited by 28
Huang, H.-Y., Yu, H.-T., Chan, S.-H., Lee, C., Wang, H., & Soong, Y. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.132 · Cited by 28
“adenomyosis, including changes in both cellular and humoral immunity, an increasing number of macrophages and immune cells, and deposition of immunoglobulin and complement components (7).”
BackgroundInfluentialEffects of LNG-IUS on nerve growth factor and its receptors expression in patients with adenomyosis
Choi, Y. S., Cho, S., Lim, K. J., Jeon, Y. E., Yang, H. I., Lee, K. E., Heena, K., Seo, S. K., Kim, H. Y., & Lee, B. S. (2010) · Growth Factors · doi:10.3109/08977194.2010.511619 · Cited by 28
“Dysmenorrhea may be due to uterine irritability which, in turn, is secondary to increased amounts of blood loss or intramyometrial pressure due to the accumulation of menstrual blood within foci of adenomyosis (Bergeron et al. 2006).”
BackgroundPhilip, C., Mitouard, M. L., Maillet, L., de Saint-Hilaire, P., Huissoud, C., Cortet, M., & Dubernard, G. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.04.001 · Cited by 28
Shinohara, S., Okuda, Y., Hirata, S., & Suzuki, K. (2020) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.251.231 · Cited by 27
“…form of the disease characterized by foci of endometrial mucosa scattered throughout the uterine musculature; and (2) focal adenomyosis, in which the area of the hypertrophic and distorted endometrium and myometrium is restricted (Byun et al. 1999; Bergeron et al. 2006; Tamura et al. 2017).”
BackgroundOtgontuya, A., Jeng, C., Wu, T.-N., Chuang, L. T., & Shen, J. (2023) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2022.11.009 · Cited by 27
Long, L., Chen, J., Xiong, Y., Zou, M., Deng, Y., Chen, L., & Wang, Z. (2015) · PubMed Central · Cited by 27
The human periconceptional maternal-embryonic space in health and disease
Moreno, I., Capalbo, A., Mas, A., Garrido‐Gómez, T., Rosón, B., Poli, M., Dimitriadis, E., Santamaría, X., Vilella, F., & Simón, C. (2023) · Physiological Reviews · doi:10.1152/physrev.00050.2021 · Cited by 32
Hai, N., Hou, Q., & Guo, R. (2021) · International Journal of Hyperthermia · doi:10.1080/02656736.2021.1874063 · Cited by 26
“Adenomyosis typically involves an irregular and massive myometrium [15].”
BackgroundPossible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis
Xu, X., Cai, X., Liu, X., & Guo, S. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00711-6 · Cited by 31
Gong, C., Wang, Y., Lv, F., Zhang, L., & Wang, Z. (2022) · International Journal of Hyperthermia · doi:10.1080/02656736.2022.2052366 · Cited by 26
“Adenomyosis is a common benign disease among women of reproductive age, which is defined by the presence of endometrial glands and stroma within the myometrium [1,2].”
BackgroundNie, J., Liu, X., Zheng, Y., Geng, J.-G., & Guo, S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.09.027 · Cited by 26
FitzGerald, J. M., Patrick, D. M., Strathdee, S. A., Rekart, M. L., Elwood, R. K., Schechter, M. T., Montaner, J., & O'Shaughnessy, M. (1999) · PubMed · Cited by 26
An axonemal alteration in apical endometria of human adenomyosis
Khan, K. N., Fujishita, A., Suematsu, T., Ogawa, K., Koshiba, A., Mori, T., Itoh, K., Teramukai, S., Matsuda, K., Nakashima, M., et al. (2021) · Human Reproduction · doi:10.1093/humrep/deab090 · Cited by 25
A mass spectrometric insight into the origins of benign gynecological disorders
Yang, H., Lau, W. B., Lau, B., Yu, X., Zhou, S., Zhao, L., Luo, Z., Lin, Q., Ren, N., Zhao, X., et al. (2015) · Mass Spectrometry Reviews · doi:10.1002/mas.21484 · Cited by 25
The Disease Phenotype of Adenomyosis-Affected Women Correlates With Specific Serum Cytokine Profiles
Bourdon, M., Santulli, P., Chouzenoux, S., Maignien, C., Bailly, K., Andrieu, M., Millischer, A., Doridot, L., Marcellin, L., Batteux, F., et al. (2018) · Reproductive Sciences · doi:10.1177/1933719118816852 · Cited by 25
The Effects of Anti-TGF-β1 on Epithelial–Mesenchymal Transition in the Pathogenesis of Adenomyosis
Kay, N., Huang, C., Shiu, L., Yu, Y.-C., Chang, Y., Suen, J., Tsai, E., & Huang, S.-T. J. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00139-0 · Cited by 26
Wan, L., Zou, Y., Wan, L., Wang, L., Huang, M., Wu, J., Zhu, Y., & Huang, O. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3766-2 · Cited by 26
“Clinically, hysterectomy was usually used for the treatment of severe adenomyosis; however, this would lead to loss of fertility and severe trauma in patients suffering from this operation [6, 7].”
BackgroundCozzolino, M., Pellicer, N., Galliano, D., & Pellicer, A. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.09.023 · Cited by 24
Quercetin alleviates generalized hyperalgesia in mice with induced adenomyosis
Nie, J., & Liu, X. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7238 · Cited by 23
“For severe, symptomatic adenomyosis, hysterectomy is the treatment choice (4), which can be traumatic for women wishing to conceive.”
BackgroundBerner, E., Qvigstad, E., Myrvold, A. K., & Lieng, M. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13362 · Cited by 22
Serum Osteopontin Levels Are Decreased in Focal Adenomyosis
Streuli, I., Santulli, P., Chouzenoux, S., Chapron, C., & Batteux, F. (2016) · Reproductive Sciences · doi:10.1177/1933719116669054 · Cited by 22
“Adenomyosis, a frequent chronic gynecological condition defined by the benign ectopic invasion of endometrial tissue—glands and stroma—into the myometrium with hyperplasia of adjacent uterine smooth muscle cells, is often associated with endometriosis.(23,24) Both entities, endometriosis and adenomyosis, share clinica…”
BackgroundBiological differences between focal and diffuse adenomyosis and response to hormonal treatment
Khan, K. N., Fujishita, A., Koshiba, A., Mori, T., Kuroboshi, H., Ogi, H., Itoh, K., Nakashima, M., & Kitawaki, J. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.12.015 · Cited by 22
Wu, H., Tsai, T.-C., Liu, S.-M., Pai, A. H.-Y., & Chen, L.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168937 · Cited by 21
“As one of the most accepted theories, adenomyotic lesions grow from an enhanced invasion of the endometrium into the myometrium through an interrupted or absent junctional zone [35] (Figure 2).”
BackgroundBerner, E., Qvigstad, E., Myrvold, A. K., & Lieng, M. (2013) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2013.10.011 · Cited by 21
Reproductive one health in primates
Moresco, A., Feltrer, Y., Wolfman, D. J., & Agnew, D. W. (2021) · American Journal of Primatology · doi:10.1002/ajp.23325 · Cited by 21
Bourdon, M., Maget, A. S., Jeljeli, M. M., Doridot, L., Marcellin, L., Thomas, M., Chêne, C., Chouzenoux, S., Batteux, F., Chapron, C., et al. (2023) · Human Reproduction · doi:10.1093/humrep/dead246 · Cited by 23
Kay, N., Huang, C., Shiu, L., Yu, Y.-C., Chang, Y., Schatz, F., Suen, J., Tsai, E., & Huang, S.-T. J. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00308-1 · Cited by 20
Correlation between Adenomyosis and Endometrial cancer: 6-year experience of a single center.
Zouzoulas, O. D., Tsolakidis, D., Efstratiou, I., Pervana, S., Pazarli, E., & Grimbizis, G. (2018) · PubMed Central · Cited by 20
Fraser, I. S. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.013 · Cited by 20
Valdés‐Bango, M., Ros, C., Daza, M., Rius, M., Gràcia, M., Martínez‐Zamora, M. Á., de Guirior, C., Quintas, L., & Carmona, F. (2024) · Human Reproduction · doi:10.1093/humrep/deae105 · Cited by 19
Altered VEGF, Bcl-2 and IDH1 expression in patients with adenomyosis
Yalaza, C., Canacankatan, N., Gürses, İ., Aytan, H., & Taşdelen, B. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05742-9 · Cited by 19
Medical Therapies for Chronic Menorrhagia
Nelson, A. L., & Teal, S. B. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000259228.70277.6f · Cited by 19
“Adenomyosis can cause chronic menorrhagia and is particularly common in parous women in the perimenopause (11).”
BackgroundKhan, K. N., Fujishita, A., Kitajima, M., Masuzaki, H., Nakashima, M., & Kitawaki, J. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.05.012 · Cited by 19
An, M., Duan, H., & Zhang, Y. (2020) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14371 · Cited by 18
Unveiling the Pathogenesis of Adenomyosis through Animal Models
Wang, X., Benagiano, G., Liu, X., & Guo, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061744 · Cited by 19
Heo, S. H., Lee, K.-H., Kim, J. W., & Jeong, Y. Y. (2011) · British Journal of Radiology · doi:10.1259/bjr/24318075 · Cited by 18
“The location of uterine adenomyosis is commonly intramural and less frequently subserosal [2].”
BackgroundBourdon, M., Santulli, P., Kateb, F., Pocate-Cheriet, K., Batteux, F., Maignien, C., Chouzenoux, S., Bordonné, C., Marcellin, L., Bertho, G., et al. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.02.031 · Cited by 20
Chen, Y., Wang, J.-H., Yan, J., Liang, Y., Zhang, X., & Zhou, F. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.11.025 · Cited by 19
“Adenomyosis is an ovarian steroid hormone-dependent disease [1].”
BackgroundGuan, Y.-G., Liao, J.-B., Li, K., Li, Y., Song, Y., Jing, L., & Su, Z. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/982913 · Cited by 17
“However, their use is confined by short duration and easy recurrence after discontinuation of therapy [6, 7].”
BackgroundAdenomyosis: Disease, uterine aging process leading to symptoms, or both?
Πρωτόπαπας, Α., Grimbizis, G., Athanasiou, S., & Loutradis, D. (2020) · PubMed Central · Cited by 17
Mesenchymal Tumors of the Uterus
Oliva, E., Zaloudek, C. J., & Soslow, R. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-46334-6_10 · Cited by 18
A pilot study on the use of andrographolide to treat symptomatic adenomyosis
Liu, X., Yu, S., & Guo, S. (2014) · Gynecology and Minimally Invasive Therapy · doi:10.1016/j.gmit.2014.12.002 · Cited by 16
Increased expression of nuclear factor kappa-B p65 subunit in adenomyosis
Park, H., Kim, S. H., Cho, Y. M., Ihm, H. J., Oh, Y. S., Hong, S. H., Chae, H. D., Kim, C., & Kang, B. M. (2016) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2016.59.2.123 · Cited by 16
“Although some women with adenomyosis are asymptomatic, the condition often causes diffusely enlarged uterus, menorrhagia, dysmenorrhea, and subfertility [1,2].”
BackgroundXu, W., Song, Y., Li, K., Zhang, B., & Zhu, X. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s265066 · Cited by 21
“Unfortunately, although surgical treatment is regarded as the definitive therapy for adenomyosis, it can be traumatic for women who are symptomatic but have a strong desire to conceive.(11,12) In addition, evidence has shown several limitations of the medical approaches, including severe premenopausal symptoms, freque…”
BackgroundInvestigation of the role of platelets in the aetiopathogenesis of adenomyosis
Mosele, S., Stratopoulou, C. A., Camboni, A., Donnez, J., & Dolmans, M. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.01.009 · Cited by 16
The Role of Abnormal Uterine Junction Zone in the Occurrence and Development of Adenomyosis
Xie, T., Xu, X., Yang, Y. L., Wu, C., Liu, X., Zhou, L., & Song, Y. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00684-2 · Cited by 16
Mesenchymal uterine tumors, other than pure smooth muscle neoplasms, and adenomyosis
McCluggage, W. G., & Robboy, S. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-07477-6.50022-6 · Cited by 16
Wang, Y., Jia, Y., Franken, P., Smits, R., Ewing, P. C., Lydon, J. P., DeMayo, F. J., Burger, C. W., Grootegoed, J. A., Fodde, R., et al. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.05.026 · Cited by 16
“and glandular cells from the endometrium reminiscent for a human disorder described as endometriosis interna or adenomyosis (Bergeron et al., 2006).”
Surgical Management of Abnormal Uterine Bleeding in Fertile Age Women
Finco, A., Centini, G., Lazzeri, L., & Zupi, E. (2015) · Women s Health · doi:10.2217/whe.15.12 · Cited by 15
Wang, D.-G., Ji, L., Jia, C.-L., & Shao, M. (2023) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2023.07.004 · Cited by 14
Zipponi, M., Cacciottola, L., & Dolmans, M. (2024) · Human Reproduction · doi:10.1093/humrep/deae116 · Cited by 14
Adenomyosis-associated infertility: an update of the immunological perspective
Cao, Y., Yang, D., Cai, S., Yang, L., Yu, S., Geng, Q., Mo, M., Li, W., Wei, Y., Li, Y., et al. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104703 · Cited by 20
Cai, X., Shen, M., Liu, X., & Nie, J. (2018) · Reproductive Sciences · doi:10.1177/1933719118773490 · Cited by 14
“Progestogenic agents are not very effective, and the efficacy of gonadotropin-releasing hormone (GnRH) agonists is restricted by their short duration.(2) In addition, symptoms often recur after discontinuation of GnRH agonists therapy,(4) leaving the only perpetual effective treatment as hysterectomy.”
BackgroundExpression of Nerve Injury-Induced Protein1 (Ninj1) in Endometriosis
Miyashita‐Ishiwata, M., Koga, K., Takeuchi, A., Makabe, T., Taguchi, A., Urata, Y., Izumi, G., Takamura, M., Harada, M., Hirata, T., et al. (2018) · Reproductive Sciences · doi:10.1177/1933719118806395 · Cited by 14
Cystic adenomyosis spreading into subserosal-peduncolated myoma
Calagna, G., Cucinella, G., Tonni, G., Gregorio, R. D., Triolo, O., Martorana, A., Perino, A., & Granese, R. (2015) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2015.01.005 · Cited by 14
Drug Development in Endometriosis and Adenomyosis: It Takes More Than Just Good Science
Groothuis, P. G., & Guo, S.-W. (2018) · Reproductive Sciences · doi:10.1177/1933719118785767 · Cited by 13
Characteristics of histologically confirmed endometriosis in cynomolgus monkeys
Nishimoto-Kakiuchi, A., Netsu, S., Matsuo, S., Hayashi, S., Ito, T., Okabayashi, S., Yasmin, L., Yuzawa, K., Kondoh, O., Kato, A., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew209 · Cited by 13
“Adenomyosis was diagnosed by histopathological criteria (the presence of endometriotic gland and stromal cells in the inner 90% of the myometrium of the uterine wall) (Bergeron et al., 2006; Sato et al., 2012).”
Uterine artery embolisation in women with symptomatic adenomyosis
Lohle, P. N. M., Higué, D., & Herbreteau, D. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.03.013 · Cited by 13
Epigenetic regulation of Progesterone Receptor isoforms: From classical models to the sexual brain
Vázquez-Martínez, E. R., Mendoza‐Garcés, L., Vergara, E., & Cerbón, M. A. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.05.011 · Cited by 12
da Silva, J. R., Andres, M. P., Leite, A. P. K., Gomes, M. T. N. D. A., Neto, J. S., Baracat, E. C., Carmona, F., & Abrão, M. S. (2020) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2020.11.001 · Cited by 12
“The gold standard for the diagnosis of adenomyosis is the histological evaluation of affected tissue samples, whether from hysterectomy, adenomyomectomy, or uterine biopsy [4-7].”
BackgroundOno, Y., Ota, H., Takimoto, K., Tsuzuki, Y., Nakajima, A., Yoshino, O., Unno, N., Fujino, T., Fukushi, Y., & Wada, S. (2021) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2021.102114 · Cited by 12
Zanolli, N. C., Cline, B. C., Befera, N. T., & Martin, J. G. (2021) · Clinical Imaging · doi:10.1016/j.clinimag.2021.11.012 · Cited by 12
Effects of Levonorgestrel-Releasing Intrauterine System on Lymphangiogenesis of Adenomyosis
Cho, S., Choi, Y. S., Yun, B. H., Chon, S. J., Jung, Y. S., Kim, H. Y., Park, J. H., Seo, S. K., Kim, S. H., & Lee, B. S. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpp8f4sfyfvxrn · Cited by 12
Aydın, H. A., Toptaş, T., Bozkurt, S., Peştereli, E., & Şimşek, T. (2017) · Tumori Journal · doi:10.5301/tj.5000698 · Cited by 12
Wildemeersch, D. A., Andrade, A. T. L., Goldstuck, N. D., Hasskamp, T., & Jackers, G. (2017) · International Journal of Women s Health · doi:10.2147/ijwh.s122579 · Cited by 12
Wolde, T., Huang, J. H., Huang, P., Pandey, V., & Qin, P. (2024) · BioMedInformatics · doi:10.3390/biomedinformatics4010019 · Cited by 11
Wang, X., Cai, W., Liang, T., Li, H., Gu, Y., Wei, X., Zhang, H., & Yang, X. (2024) · European Journal of Histochemistry · doi:10.4081/ejh.2024.4131 · Cited by 11
Navigating through perplex morphologic changes after exogenous hormone usage
Chang, R., Rivera-Colón, G., Chen, H., Niu, S., Carrick, K. S., Lucas, E., Gwin, K., & Zheng, W. (2021) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2021.10.001 · Cited by 11
An update on adenomyosis uteri
Hong, S. C., & Khoo, C. K. (2015) · Gynecology and Minimally Invasive Therapy · doi:10.1016/j.gmit.2015.08.003 · Cited by 11
Ding, X., Wang, L., Ren, Y., & Zheng, W. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800325 · Cited by 11
Hertlein, L., Rath, J., Zeder-Göß, C., Fürst, S. T., Bayer, D., Trillsch, F., Mahner, S., Burges, A., & Jeschke, U. (2017) · Oncology Letters · doi:10.3892/ol.2017.6592 · Cited by 11
“In hysterectomy specimens obtained during the treatment of EEC, AM may be found in 16-42% (3-6).”
BackgroundIn the mouse, prostaglandin D2 signalling protects the endometrium against adenomyosis
Philibert, P., Déjardin, S., Pirot, N., Pruvost, A., Nguyen, A. L., Bernex, F., Poulat, F., & Boizet‐Bonhoure, B. (2021) · Molecular Human Reproduction · doi:10.1093/molehr/gaab029 · Cited by 11
Liu, D., Yin, X., Guan, X., & Li, K. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1082709 · Cited by 11
“The most widely accepted theory for the etiology of adenomyosis is the invagination of the basalis endometrium into the myometrium (Bergeron et al., 2006), which indicates FIGURE 5 Validation of hub genes using qRT-PCR.”
MethodAslan, K., Sarı, M. E., Yalçın, H. R., Yalçın, İ., Cüylan, Z. F., & Özdal, B. (2020) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02172-z · Cited by 11
Subserous Cystic Adenomyosis: A Case Report and Review of the Literature
Xu, T., Li, Y., Jiang, L., Liu, Q., & Liu, K. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.807676 · Cited by 10
“Adenomyosis is a common gynecological disease in gynecology caused by the infiltration of the myometrium by the glands and stroma of the endometrium (28).”
BackgroundImpact of Adenomyosis on Infertile Patients—Therapy Options and Reproductive Outcomes
Günther, V., Allahqoli, L., Gitas, G., Maass, N., Tesch, K., Ackermann, J., Rosam, P., Mettler, L., von Otte, S., & Alkatout, İ. (2022) · Biomedicines · doi:10.3390/biomedicines10123245 · Cited by 10
“Thus, the disease appears to be estrogen-dependent and can be reactivated post-menopause in cases of preexisting lesions [7].”
BackgroundDown-regulation of tumor suppressor PDCD4 expression in endometrium of adenomyosis patients
Liu, Y., Tan, X., Wang, Z., Li, Y., Gao, M. Q., Li, Y., Fang, Z., Sun, Y., Zhang, L., Wang, X., et al. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.04.008 · Cited by 10
Adjuvant therapy in conservative surgery for adenomyosis
Chao, X., Song, X., Wu, H., You, Y., Li, L., & Lang, J. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13573 · Cited by 10
Barriers to self‐management of patients with adenomyosis: A qualitative study
Huang, R., Li, X., Jiang, H., & Li, Q. (2021) · Nursing Open · doi:10.1002/nop2.1148 · Cited by 10
“The major clinical manifestations of adenomyosis include menorrhagia, dysmenorrhea, infertility, chronic pelvic pain and enlarged uterine volume (Bergeron et al., 2006; Farquhar & Brosens, 2006).”
BackgroundLi, B., Qi, J., Cao, Y., Long, Y., Wei, Z., Wang, W., Hu, S., Wang, Y., Zhu, Q., Hu, X. J., et al. (2025) · Advanced Science · doi:10.1002/advs.202411752 · Cited by 10
Guo, Z., Duan, H., Wang, S., Wang, S., Lin, Q., & Li, Y. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01871-2 · Cited by 9
“The diagnosis of adenomyosis was confirmed by histological examination by two pathologists as the presence of ectopic endometrial tissue (endometrial stroma and glands) within the myometrium [30].”
Method
Metadata
- Authors
- Bergeron, C., Amant, F., & Ferenczy, A.
- Affiliations
- Processus d'Activation Sélective par Transfert d'Énergie Uni-électronique ou Radiatif (FR)
- Jewish General Hospital (CA)
- Corresponding author
- Bergeron, Christine
- ORCID
- Bergeron, Christine
- Venue
- Best Practice & Research Clinical Obstetrics & Gynaecology
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 20
- Issue
- 4
- Pages
- 511-521
- ISSN
- 1521-6934 (ISSN-L)
- OpenAlex
- W2038354928
- Cited by
- 359
- References
- 54
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 19 · 2023: 33 · 2022: 25 · 2021: 36 · 2020: 35 · 2019: 26 · 2018: 19 · 2017: 20 · 2016: 19 · 2015: 27 · 2014: 18 · 2013: 10 · 2012: 11
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Best Practice & Research Clinical Obstetrics & Gynaecology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- adenomyosis, anti-apoptotic effects, hyperoestrogenism, menorrhagia, dysmenorrhea, endometrial polyps, uterine fibroids, endometrioid carcinoma, hysterectomy, danazol, GnRH analogues, progestogens, surgical treatment
- MeSH terms
- Adult, Danazol, Endometrial Hyperplasia, Endometriosis, Estrogen Antagonists, Female, Humans, Hysterectomy, Leiomyoma, Gonadotropin-Releasing Hormone, Middle Aged, Polyps, Uterine Diseases, Uterine Neoplasms, Endometrial Neoplasms, Carcinoma, Endometrioid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review